Steven O'Day - Jan 4, 2022 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Chief Medical Officer
Signature
/s/ Steven J. O'Day
Stock symbol
AGEN
Transactions as of
Jan 4, 2022
Transactions value $
-$118,346
Form type
4
Date filed
1/6/2022, 04:47 PM
Previous filing
Jan 4, 2022
Next filing
Feb 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGEN Common Stock Options Exercise +100K 100K Jan 4, 2022 Direct F1
transaction AGEN Common Stock Sale -$118K -38.7K -38.68% $3.06 61.3K Jan 6, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Restricted Stock Units Options Exercise $0 -100K -100% $0.00* 0 Jan 4, 2022 Common Stock 100K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements related to the vesting. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.055 to $3.065. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 On January 4, 2021, the reporting person was granted 100,000 restricted stock units that fully vested on January 4, 2022.